← BIO-TECHNE Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $104.5m |
$76.1m
-27.17%
|
$126.2m
+65.80%
|
$96.1m
-23.84%
|
$229.3m
+138.67%
|
$140.4m
-38.76%
|
$272.1m
+93.75%
|
$285.3m
+4.86%
|
$168.1m
-41.07%
|
$73.4m
-56.34%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | $126.0m |
$96.0m
-23.86%
|
$229.1m
+138.70%
|
$140.3m
-38.74%
|
$271.9m
+93.79%
|
$285.2m
+4.88%
|
$168.1m
-41.07%
|
$73.4m
-56.35%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | $139.6m | $263.1m | $285.4m | $168.1m | $73.4m | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | ($825k) | ($9.0m) | $179k | — | — | — | |
| Depreciation, Depletion and Amortization | $42.8m | $60.0m | $64.5m | $78.2m | $82.7m | $87.7m | $101.1m | $107.2m | $111.7m | $109.9m | $100.3m | |
| Amortization of Intangible Assets | — | $44.4m | $47.1m | $58.7m | $61.1m | $64.9m | $74.1m | $77.5m | $79.9m | $76.0m | — | |
| Deferred Income Tax Expense (Benefit) | ($2.6m) | ($3.4m) | ($46.7m) | ($14.0m) | $13.6m | ($28.0m) | $7.1m | ($29.8m) | ($40.2m) | ($51.2m) | ($24.2m) | |
| Share-based Payment Arrangement, Noncash Expense | $9.4m | $14.6m | $28.2m | $32.3m | $32.4m | $49.0m | $42.2m | $39.2m | $38.0m | $40.8m | $40.7m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | $23.5m | $28.9m | $21.9m | $6.5m | — | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | $46.4m | $41.2m | $40.3m | — | $40.7m | |
| Goodwill and Intangible Asset Impairment | — | — | — | — | — | — | $18.7m | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | $92.0m | |
| Impairment of Intangible Assets (Excluding Goodwill) | $0 | — | — | — | — | — | — | — | — | — | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | — | $0 | — | — | $73.3m | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | — | $8.6m | — | — | — | — | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | — | — | — | — | — | $1.1m | $6.8m | $938k | — | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | — | ($1.1m) | ($6.8m) | $938k | — | |
| Nonoperating Income (Expense) | ($3.1m) | ($8.6m) | ($10.2m) | ($34.7m) | $119.1m | ($89.1m) | $4.8m | $39.7m | ($21.0m) | ($3.8m) | — | |
| Other Nonoperating Income (Expense) | ($1.6m) | ($1.6m) | ($447k) | ($13.6m) | $137.7m | ($75.6m) | $15.3m | $47.5m | ($8.6m) | $831k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Inventories | $6.6m | $732k | $13.3m | $13.6m | $14.9m | $7.1m | $32.0m | $30.2m | $14.2m | $18.1m | ($19.1m) | |
| Net Cash Provided by (Used in) Operating Activities | $143.9m |
$143.4m
-0.29%
|
$170.4m
+18.77%
|
$181.6m
+6.60%
|
$205.2m
+12.99%
|
$352.2m
+71.61%
|
$325.3m
-7.64%
|
$254.4m
-21.79%
|
$299.0m
+17.53%
|
$287.6m
-3.82%
|
$294.9m
+2.54%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $16.9m | $15.2m | $20.9m | $25.4m | $51.7m | $44.3m | $44.9m | $38.2m | $62.9m | $31.0m | ($25.3m) | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | $49.3m | $283k | — | — | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $776k | $6.1m | $36.4m | $21.6m | $147.1m | $66.4m | $26.1m | $35.2m | — | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | $91.4m | $253.8m | $67.9m | $289.5m | $0 | $225.4m | — | $101.2m | $169.7m | — | $0 | |
| Payments for (Proceeds from) Other Investing Activities | $25k | — | ($680k) | — | $0 | $0 | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($107.6m) | ($306.0m) | ($38.7m) | ($336.8m) | $27.1m | ($243.5m) | ($96.9m) | ($265.6m) | ($203.0m) | ($35.2m) | ($10.7m) | |
| Cash flows from financing activities: | ||||||||||||
| Debt and Equity Securities, Realized Gain (Loss) | — | — | — | — | — | — | — | $1.1m | $300k | ($938k) | — | |
| Payments for Repurchase of Common Stock | — | — | — | $15.4m | $50.1m | $43.2m | $160.9m | $19.6m | $80.0m | $275.7m | — | |
| Payments of Ordinary Dividends, Common Stock | $47.6m | $47.3m | $48.0m | $48.4m | $48.9m | $49.6m | $50.2m | $50.3m | $50.4m | $50.4m | ($49.8m) | |
| Proceeds from (Payments for) Other Financing Activities | — | — | ($4.0m) | ($6.3m) | ($3.9m) | ($19.3m) | $788k | ($2.5m) | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | ($23.1m) |
$189.4m
+920.46%
|
($99.2m)
-152.37%
|
$134.4m
+235.48%
|
($183.8m)
-236.77%
|
($62.6m)
+65.97%
|
($242.9m)
-288.25%
|
$22.6m
+109.31%
|
($122.4m)
-641.20%
|
($253.9m)
-107.44%
|
($226.4m)
+10.85%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($3.5m) | $495k | ($2.1m) | ($308k) | $45.7m | $52.5m | ($26.5m) | $8.0m | ($28.8m) | $10.4m | $198.4m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $5.5m | $5.3m | $19.2m | $38.0m | $71.0m | $65.1m | $77.2m | $29.8m | $60.9m | $51.7m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $7.5m | $9.8m | $21.5m | $18.6m | $13.6m | $11.0m | $8.4m | $14.5m | $19.0m | — | |
| Income Taxes Paid, Net | — | $42.9m | $35.1m | $36.8m | $42.0m | $21.0m | $30.3m | $88.4m | $65.3m | $74.4m | — | |
| Additional Financial Items | ||||||||||||
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | — | — | ($3.5m) | — | — | |
| Goodwill | $430.9m | $579.0m | $597.9m | $732.7m | $728.3m | $843.1m | $822.1m | $872.7m | $972.7m | $980.9m | $92.0m | |
| Income Tax Expense (Benefit) | $43.0m | $35.9m | ($198k) | $15.9m | $47.2m | $8.6m | $38.3m | $53.2m | $17.6m | $25.1m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $15.7m | $8.5m | — | |
| Operating Expenses | $186.1m | $254.0m | $296.0m | $326.8m | $325.8m | $395.6m | $459.9m | $470.9m | $563.0m | $688.0m | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $643.0m | $714.0m | $738.7m | — | — | — | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.